School of Medicine

Wayne State University School of Medicine

Profile View

Return To Profile List
Harold E. Kim, M.D.
Associate Professor
Wayne State University - Medicine
Radiation Oncology
 
kimh@med.wayne.edu
Biography
EDUCATION
09/79-06/83       Loyola University of Chicago, Chicago, IL, B.S. in Biology
09/83-06/87       Northestern University Medical School, Chicago, IL , M.D.
 
POSTDOCTORAL TRAINING
07/87-06/88       Resident, Internal Medicine, Northwestern Memorial Hospital, Northwestern University Medical School, Chicago, IL
09/88-09/91       Resident, Radiation Oncology, Northwestern Memorial Hospital, Northwestern University Medical School, Chicago, IL
 
FELLOWSHIP
09/91-09/92       The Edward Mallinkrodt Institute of Radiology, Washington University Medical School, St. Louis, MO
 
FACULTY APPOINTMENTS
1995-2006         Assistant Professor, Dept of Radiation Oncology, Wayne State University School of Medicine, Detroit, MI
2006-present    Associate Professor, Dept of Radiation Oncology, Wayne State University School of Medicine, Detroit, MI                                     
                                              
HOSPITAL APPOINTMENTS
1992 - Attending Radiation Oncologist, Oncology Care Center, Belleville, IL
 
1993 - Attending Radiation Oncologist, St. Joseph Hospital, Pontiac, MI
 
1993-1995 - Attending Radiation Onoclogist, Grant Medical Center, Columbus, OH
 
1995-1997 - Attending Physician and Clinical Chief, DMC Crittenton Radiation Oncology Ctr, Rochester, MI 

1995-present - Attending Physician, Gershenson Radiation Oncology Ctr, Karmanos Cancer Ctr, Detroit, MI

2003-2004 -Clinical Chief, Gershenson Radiation Oncology Ctr, Karmanos Cancer Ctr, Detroit, MI

1999-2007 - Consultant, Dept of Radiation Oncology, John D. Dingell Veterans Administration Med Ctr, Detroit, MI 

Awards & Honors
Excellence in Service, Research & Teaching Faculty Award, Dept of Otolaryngology, Wayne State University Medical School (June 26, 2002)
Featured in Wayne Medicine, 2005
Publications
  1. Lai P, Berstein M, Kim HE, Perez CA, Wasserman TH, Kucik NA. Radiation therapy for stage I and IIA testicular seminoma. Int J Rad Oncol Biol Phys. 1994; 28(2): 373-9.
  2. Kim HE, Han SJ, Kasza T, Han R, Choi HS, Plamer KC, Kim HRC. Platelet0-   derived growth factor (PDGF) signaling mediates radiation-induced apoptosis in human prostate cancer with loss of p53 function. Int J Rad Oncol Biol Phys. 1997; 39(3): 731-6.
  3. Kim HRC, Li G, Kim HE, Han S, Rahman KH, Liu H, Lee Y. Levels of p21WAF1/CIP1 do not affect radiation-induced cell death in human breast epithelial cells. Int J Onc. 1997; 11:1349-53.
  4. Kim HE. Meeting nutritional needs after head and neck surgery. Canc Prac. 1999; 7(1): 5-9.
  5. Kim HE, Krug MA, Han K, Ensley J, Yoo GH, Forman KD, Kim HRC. Neutron radiation enhances Cisplatin cytotoxicity independent of apoptosis in human head and neck carcinoma cells. Clin Canc Res. 2000; 6(10): 4142-7.
  6. Moon A, Kim MS, Kim TG, Kim SH, Kim HE, Chen YQ, Kim HR. H-ras, but no N-ras, induces an invasive phenotype in human breast epithelial cells: a role for MMP-2 in the H-ras-induced invasive phenotype. Int J Canc. 2000; 85(2): 176-81.
  7. Ensley JF, Youssef E, Kim HE, Yoo GH. Locally advanced nasopharyngeal cancer. Curr Treat Opt Onc. 2001; 2(1): 15-23.
  8. Yoo GH, Washington J, Oliver J, Piechocki M, Kim HE, Foster-Nora J, Wilson D, Tainsky M, Ensley JF. The effects of exogenous p53 over-expression on HPV-immortalized and carcinogen transformed oral keratinocytes. Canc. 2002; 94(1): 159-66.
  9. Piechocki M, Lonardo F, Ensley J, Nguyen T, Kim HE, Yoo GH. Anticancer activity of Docetaxel in murine salivary gland carcinoma. Clin Canc Res. 2002; 8(3): 870-7.
  10. Yoo GH, Piechocki MP, Lonardo F, Meng H, Kewson D, Shibuya TY, Kim HE, Stachler R, Ensley JF. In vivo characteristics of HPV-immortalized and carcinogen transformed oral keratinocytes. Laryngoscope. 2002; 112(9): 1672-9.
  11. Cooper J, Pajak T, Forastiere A, Jacobs J, Saxman S, Kish K, Kim HE, Cmelak A, Rotman M, Machtay M, Ensley J, Chao C, Schultz C, Lee N, Fu K. Postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck: The RTOG 9501/Intergroup Phase III Trial. New Eng J Med. 2004; 350(19): 1937-44.
  12. Shehadeh NJ, Vernick J, Lonardo F, Madan S, Jacobs J, Yoo GH, Kim HE, Ensley J. Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: A case report and review of the literature. Am J Otolaryng. 2004; 25(1): 48-53.
  13. Otereo-Garcia JE, Merati K, Du D, Youssef E, Lonardo F, Jacobs J, Yoo GH, Kim HE. Prognostic significance of p53 and FHIT in advanced oropharyngeal carcinoma. Am J Otolaryng. 2004; 25(4): 231-9.
  14. Enamorado I, Lakhani R, Yoo GH, Pietraszkiewicz H, Maciorowski Z, Sakr
    WA, Kim HE, Kucuk O, Jacobs J, Ensley J. Correlation of histopathological variants, cellular DNA content and clinical outcome in adenoid cystic carcinoma of the salivary glands. Otolaryng Head Neck Surg. Nov. 2004; 131(5): 646-650
  15. Yoo GH; Piechocki MP; Oliver J; Lonardo F; Zumstein L; Kim HE; Shibuya TY; Shehadeh N; Ensley JF; Enhancement of Ad-p53 therapy with Docetaxel in Head and Neck Cancer. Laryngoscope Nov 2004; 114: 1871-1879
  16. Korkmaz H; Du W; Yoo GH; Enamorado II; Lin HS; Adsay V; Kewson D; Ensley JF; Shibuya TY; Jacobs JR; Kim HE. Prognostic significance of G1 cell cycle inhibitors in early laryngeal cancer. Am J Otolaryngology 2005 Mar-Apr; 26(2): 77-82.
  17. Yoo, GH; Lin, HS; Iskander, AJ; Piechocki, MP; Oliver, J; Kewson, D; Lonardo, F; Tainsky, MA; Kim, HR; Kim, HE; Ensley, JF:  Docetaxel associated pathways in Cisplatin resistant Head and Neck Squamous Carcinoma Cells. Laryngoscope, 2005 Nov; 115(11): 1938-46 BMS275183 Induced Gene Expression Patterns in Head and Neck Carcinoma (In Press, Head and Neck)
  18. Yoo, GH; Iskander, J; Ezzat, WH; Piechocki, MP; Oliver, J; Ensley, J F; Lemmonier, L; Lonardo, F; Kim, HE; Lin, HS; Rose, WC.
  19. Elliott EA, Wright J.R, Swann SR, Nguyen-Tan PF, Takita C, Bucci K, Garden A, Kim HE, Hug EB, Ryu J, Greenberg M, Saxton JP, Ang K, Berk L.: Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13.
    J Clin Oncol. 2006 May 1; 24(13): 2092-7.
  20. Shehadeh NJ, Ensley JF, KucukO, Black C, YooGH, Jacobs J, LinHS, HeilbrunLK, SmithD, KimHE: The benefit of postoperative chemoradiotherapy treatment for patients with unknown primary squamous cell carcinoma of the head and neck. Head Neck. 2006 Dec; 28 (12): 1090-8.
  21. Ryu JK, Swann S, LeVeque F, Scarantino CW, Johnson DJM, Chen A, Fortin A, Pollack J, Kim, HE, Ang KK.: The impact of concurrent granulocyte macrophase-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: Double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901. Int. J. Radiation Oncology Bio. Phys., Vol. 67, No 3, pp 643-650, 2007